Sign in
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
LogoFinSMEs The Website About Venture Capital News
LogoFinSMEs The Website About Venture Capital News
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Home Tags Samsara BioCapital

Tag: Samsara BioCapital

palvella-logo
USA

Palvella Therapeutics Raises Up To $37.7M Series D Financing

FinSMEs -
January 9, 2023
0
Enlaza Therapeutics
USA

Enlaza Therapeutics Raises $61M in Seed Financing

FinSMEs -
December 19, 2022
0
Alpha-9 Theranostics
USA

Alpha-9 Theranostics Raises $75M in Series B Financing

FinSMEs -
December 15, 2022
0
acelyrin Logo
USA

Acelyrin Raises $300M Series C Financing

FinSMEs -
September 13, 2022
0
Delfi Diagnostics Announces $225 Million Series B Financing
USA

Delfi Diagnostics Raises $225M in Series B Financing

FinSMEs -
July 18, 2022
0
Mineralys Therapeutics
USA

Mineralys Therapeutics Closes $118M Series B Financing

FinSMEs -
June 8, 2022
0
healthcare
Switzerland

ImmunOs Therapeutics Raises $74M in Series B Financing

FinSMEs -
June 7, 2022
0
Upstream_logo
USA

Upstream Bio Raises $200M in Series A Financing

FinSMEs -
June 2, 2022
0
EyeBio_Logo
UK

EyeBiotech Raises $65M in Series A Funding

FinSMEs -
February 22, 2022
0
Seismic Therapeutic
USA

Seismic Therapeutic Launches with $101M in Series A Financing

FinSMEs -
February 9, 2022
0
dewpoint
USA

Dewpoint Therapeutics Completes $150M Series C Financing

FinSMEs -
February 3, 2022
0
septerna
USA

Septerna Raises $100M in Series A Financing

FinSMEs -
January 31, 2022
0
cancer
USA

Simcha Therapeutics Raises $40M in Series B Funding

FinSMEs -
January 31, 2022
0
healthcare
China

Ablaze Pharmaceuticals Raises $75M in Series A Financing

FinSMEs -
November 29, 2021
0
healthcare
USA

Exo Therapeutics Raises $78M in Series B Financing

FinSMEs -
October 11, 2021
0
1234Page 2 of 4
  • Contact
  • About
  • Privacy Policy
  • Advertise with Us
  • Disclaimer
  • GDPR
  • Terms & Conditions

Follow Us

Twitter